The KDIGO CKD 2024 Guideline Draft
It’s time for another NephJC draft! This time, the crew breaks down the 2024 KDIGO chronic kidney disease (CKD) guideline. This was the first update since 2012.
A First-of-its-Kind Machine Learning Model to Flag, Screen People for Elevated Lipoprotein(a)
POD1UM-303: Retifanlimab Plus Chemotherapy Improves PFS in Metastatic Squamous Cell Carcinoma of the Anal Canal
RAMTAS: Ramucirumab Plus TAS102 Shows Survival Benefit in Specific Subgroups of Metastatic Colorectal Cancer